company
Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
Industry: pharmaceutical
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_warning_letter · cgmp2026-06-03Hubei Gedian Humanwell Pharmaceutical Co., Ltd. — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (2026-06-03)
Frequently asked questions
- How many FDA warning letters has Hubei Gedian Humanwell Pharmaceutical Co., Ltd. received?
- Argus HQ has recorded 1 FDA warning letter for Hubei Gedian Humanwell Pharmaceutical Co., Ltd..
- What FDA recalls has Hubei Gedian Humanwell Pharmaceutical Co., Ltd. issued?
- Argus HQ has not recorded an FDA recall tied to Hubei Gedian Humanwell Pharmaceutical Co., Ltd. in our current dataset.
- Is Hubei Gedian Humanwell Pharmaceutical Co., Ltd. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Hubei Gedian Humanwell Pharmaceutical Co., Ltd.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

